Novolog Mix 70/30



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 19.5%
Diabetes Mellitus 14.9%
Insulin-requiring Type Ii Diabetes Mellitus 11.9%
Insulin-requiring Type 2 Diabetes Mellitus 10.7%
Hypertension 9.3%
Drug Use For Unknown Indication 8.9%
Product Used For Unknown Indication 4.7%
Type 1 Diabetes Mellitus 4.5%
Asthma 2.2%
Diabetes Mellitus Insulin-dependent 2.0%
Depression 1.8%
Blood Cholesterol Increased 1.6%
Chronic Obstructive Pulmonary Disease 1.4%
Ill-defined Disorder 1.2%
Cardiac Failure 1.2%
Prophylaxis 1.1%
Gastrooesophageal Reflux Disease 0.9%
Back Pain 0.7%
Cardiac Disorder 0.7%
Hypercholesterolaemia 0.7%
Blood Glucose Increased 13.5%
Hypoglycaemia 9.6%
Hypoglycaemic Unconsciousness 7.8%
Vomiting 6.4%
Vision Blurred 6.0%
Myocardial Infarction 5.7%
Loss Of Consciousness 5.3%
Urticaria 5.3%
Weight Increased 4.6%
Wrong Drug Administered 4.6%
Cerebrovascular Accident 4.3%
Product Quality Issue 3.9%
Death 3.5%
Palpitations 3.2%
Hypothermia 2.8%
Injection Site Urticaria 2.8%
Lower Limb Fracture 2.8%
Pneumonia 2.8%
Chest Pain 2.5%
Diabetes Mellitus Inadequate Control 2.5%
Secondary
Type 2 Diabetes Mellitus 25.0%
Diabetes Mellitus 16.8%
Insulin-requiring Type 2 Diabetes Mellitus 13.2%
Drug Use For Unknown Indication 9.2%
Hypertension 7.0%
Insulin-requiring Type Ii Diabetes Mellitus 6.5%
Product Used For Unknown Indication 6.3%
Type 1 Diabetes Mellitus 4.5%
Cardiac Failure 1.4%
Prophylaxis 1.3%
Diabetes Mellitus Insulin-dependent 1.2%
Gastrooesophageal Reflux Disease 1.2%
Blood Cholesterol Increased 1.1%
Asthma 1.0%
Blood Pressure Abnormal 1.0%
Chronic Obstructive Pulmonary Disease 1.0%
Bone Pain 0.7%
Hernia 0.7%
Hyperuricaemia 0.6%
Arterial Spasm 0.5%
Hypoglycaemia 12.2%
Blood Glucose Increased 11.6%
Wrong Drug Administered 9.5%
Urinary Tract Infection 5.4%
Abortion Induced 4.8%
Diabetes Mellitus Inadequate Control 4.8%
Hypoglycaemic Unconsciousness 4.8%
Product Quality Issue 4.8%
Fall 4.1%
Injection Site Urticaria 4.1%
Palpitations 4.1%
Pneumonia 4.1%
Syncope 4.1%
Weight Increased 4.1%
Cerebral Infarction 3.4%
Urticaria 3.4%
Hypotension 2.7%
Intentional Overdose 2.7%
Medication Error 2.7%
Nausea 2.7%
Concomitant
Drug Use For Unknown Indication 19.6%
Product Used For Unknown Indication 19.0%
Type 2 Diabetes Mellitus 12.8%
Diabetes Mellitus 12.3%
Hypertension 9.8%
Diabetes Mellitus Non-insulin-dependent 3.1%
Type 1 Diabetes Mellitus 2.8%
Prophylaxis 2.8%
Nuclear Magnetic Resonance Imaging 2.6%
Pain 2.0%
Depression 1.7%
Rheumatoid Arthritis 1.6%
Breast Cancer 1.6%
Insulin-requiring Type 2 Diabetes Mellitus 1.4%
Anxiety 1.4%
Osteoporosis 1.3%
Myocardial Ischaemia 1.2%
Sleep Disorder 1.0%
Stent Placement 1.0%
Insulin-requiring Type Ii Diabetes Mellitus 0.9%
Weight Decreased 19.8%
Vomiting 13.8%
Pancreatitis 7.8%
Syncope 6.9%
Weight Increased 6.0%
Oedema Mouth 5.1%
Nausea 4.8%
Renal Failure 4.5%
Blood Glucose Increased 3.6%
Somnolence 3.3%
Injection Site Pain 3.0%
Myocardial Infarction 3.0%
Thrombocytopenia 3.0%
Dyspnoea 2.7%
Death 2.4%
Rhabdomyolysis 2.4%
Cerebrovascular Accident 2.1%
Renal Failure Acute 2.1%
Tremor 2.1%
Lip Swelling 1.8%
Interacting
Hypertension 24.5%
Diabetes Mellitus 17.0%
Type 1 Diabetes Mellitus 17.0%
Type 2 Diabetes Mellitus 13.2%
Diabetes Insipidus 7.5%
Podagra 5.7%
Renal Failure 5.7%
Renal Failure Chronic 5.7%
Drug Use For Unknown Indication 3.8%
Renal Failure 40.0%
Malaise 30.0%
Hypoglycaemia 20.0%
Hypothermia 10.0%